RxDoctor Payments Data

Anne Marie Woodruff

Family · Saint Louis, MONPI 1538272307

Payments from drug & device makers

$2,160in general payments, 2019–2025

Across 118 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$609
  • Novo Nordisk$228
  • GSK$187
  • Pfizer$121
  • Lilly USA, LLC$117
  • AstraZeneca$106
  • plus $791 from 22 others

What the payments were for

  • Food & beverage$2,160100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,160 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$48,909
Medicare patients
320
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide16$16,604
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$7,568
MyrbetriqMirabegron12$7,420
Levothyroxine Sodium67$948
Atorvastatin Calcium41$467
Duloxetine Hcl13$322
Albuterol Sulfate HfaAlbuterol Sulfate19$316
Celecoxib18$287
Escitalopram Oxalate21$280
Metoprolol Succinate25$271
Amlodipine Besylate41$257
Diclofenac Sodium16$231
Rosuvastatin Calcium30$216
Gabapentin41$210
Lisinopril28$188

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$117$16,60416 claims
GSKTrelegy Ellipta$187$7,56813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →